Psoriasis Clinical Trials

Showing 441-460 of 888 trials

BI 655066 Versus Placebo & Active Comparator (Ustekinumab) in Patients With Moderate to Severe Chronic Plaque Psoriasis

NCT02684357

This is a randomized double blind, double dummy, placebo and active comparator controlled, parallel design study that is being performed to assess the safety and efficacy of risankizumab (BI 655066) to support registration for the treatment of moderate to severe chronic plaque psoriasis in adult patients.

Psoriasis

AbbVie577 participantsStarted Mar 2016

COMPLETEDPhase 2

Study to Evaluate the Efficacy and Safety of JTE-451 in Subjects With Moderate to Severe Plaque Psoriasis

NCT03832738

Study to evaluate the efficacy and safety of JTE-451 administered for 16 weeks in subjects with moderate to severe plaque psoriasis.

Plaque PsoriasisPsoriasisSkin Diseases

Akros Pharma Inc.152 participantsStarted Jan 2019

Santa Monica, California, United States • Temecula, California, United States • Indianapolis, Indiana, United States +30 more locations

BI 655066 Versus Placebo & Active Comparator (Ustekinumab) in Patients With Moderate to Severe Chronic Plaque Psoriasis

Study to Evaluate the Efficacy and Safety of JTE-451 in Subjects With Moderate to Severe Plaque Psoriasis

Related Searches

A Study of Ixekizumab (LY2439821) in Participants in Japan With Generalized Pustular Psoriasis and Erythrodermic Psoriasis

DC-STAMP: Regulators of Osteoclastogenesis and Response Marker in PsA

Study to Evaluate the Safety and Efficacy of JTE-051 in Subjects With Moderate to Severe Plaque Psoriasis

Informative Value of Determining the Level of NF-κB Translocation in Lymphocyte Populations in Children With Psoriasis

SystemIc iNflammation and Microvascular diSease PreventIon in psoRiatic diseasE

A Study of Guselkumab in the Treatment of Participants With Moderate to Severe Plaque-Type Psoriasis With Randomized Withdrawal and Retreatment

Topical Methotrexate Microemulsion in the Treatment of Plaque Psoriasis

COVID-19 Infection in Vulnerable Patients With Inflammatory Rheumatic Diseases

An Efficacy Study of Secukinumab In Enthesitis of Psoriatic Arthritis Patients

Induction of Regulatory t Cells by Low Dose il2 in Autoimmune and Inflammatory Diseases

Efficacy and Safety Study of Certolizumab Pegol (CZP) Versus Active Comparator and Placebo in Subjects With Plaque Psoriasis (PSO)

Risankizumab Versus Secukinumab for Participants With Moderate to Severe Plaque Psoriasis

A Study of Ixekizumab (LY2439821) in Chinese Participants With Moderate-to-Severe Plaque Psoriasis

A Clinical Investigation With Epaderm® Cream

PSOREAL - Managing PSOriasis in the REAL World

A 12-Day Randomized, Blinded, Vehicle and Active Comparator-Controlled Study to Determine the Efficacy and Safety of Six Concentrations of Topical E6201 Gel in Subjects With Psoriasis Vulgaris

Study to Evaluate APVO210 in Healthy Subjects, Patients With Psoriasis, and Patients With Ulcerative Colitis

Psoriatic Oligoarthritis Intervention With Symptomatic thErapy